Literature DB >> 9272495

"Dural tail" adjacent to a giant posterior cerebral artery aneurysm: case report and review of the literature.

C D Good1, D P Kingsley, W J Taylor, W F Harkness.   

Abstract

The "dural tail" sign on gadolinium (Gd-DTPA)-enhanced MRI has been described in association with meningiomas. Various series with histopathological correlation have shown that in some cases there is tumour invasion into the dura mater, but in the majority of cases it represents a hypervascular, non-neoplastic reaction. While this sign was originally thought to be specific for meningioma, subsequent case reports have described the presence of a dural tail in other intra- and extra-axial lesions. We present a patient with a giant aneurysm arising from the P2 segment of the right posterior cerebral artery, adjacent to the tentorium, with a prominent dural tail on Gd-DTPA-enhanced MRI. In this location, differentiation of an aneurysm from a meningioma was critical.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272495     DOI: 10.1007/s002340050470

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

1.  A review on dural tail sign.

Authors:  Houman Sotoudeh; Hadi Rokni Yazdi
Journal:  World J Radiol       Date:  2010-05-28

2.  Intraosseous hemangioma of the skull with dural tail sign: radiologic features with pathologic correlation.

Authors:  Maria Politi; Bernd F M Romeike; Panagiotis Papanagiotou; Abdullah Nabhan; Tobias Struffert; Wolfgang Feiden; Wolfgang Reith
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  The dural tail of intracranial meningiomas on fluid-attenuated inversion-recovery images.

Authors:  T Takeguchi; H Miki; T Shimizu; K Kikuchi; T Mochizuki; S Ohue; T Ohnishi
Journal:  Neuroradiology       Date:  2004-01-28       Impact factor: 2.804

Review 4.  Extra-axial brain tumors.

Authors:  Antonios Drevelegas
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 7.034

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.